SS
Supreet Singh
About Supreet Singh
Data last updated:
Supreet Singh is a Director at Psychocare Health Private Limited (since 2018), Director at Jips Pharmaceuticals Private Limited (since 2017) and Director at Kyracare Remedies Private Limited (since 2023), and holds 4 more current directorships. The companies operate in Pharma, Trading and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹68.58 Cr; the largest is Psychocare Health Private Limited at ₹40.92 Cr (FY 2024). Earlier, Supreet Singh was a Director at Future Generic Private Limited (2021–2023) and Director at Fitquest Labs Private Limited (from 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Sep 2018 | 2018 | ₹40.92 Cr (FY 2024) | Active | |
| Director | 17 Jan 2017 | 2017 | ₹27.63 Cr (FY 2023) | Active | |
| Director | 18 Mar 2023 | 2023 | ₹1.7 Lakh (FY 2025) | Active | |
| Director | 11 Aug 2022 | 2022 | ₹1.3 Lakh (FY 2025) | Active | |
| Designated Partner | 16 Dec 2024 | 2024 | Active | ||
| Director | 23 Mar 2023 | ||||
| Director | 21 Mar 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Mar 2021 | 2021 | ₹31.5 Lakh (FY 2024) | Active | |
| Director | 20 May 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Supreet Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagdeep Singh | 07672365 | Psychocare Health Private Limited , Jips Pharmaceuticals Private Limited and 5 more | Managing Director |
| Irvandeep Kaur | 07673286 | Jips Pharmaceuticals Private Limited | Director |
| Parvinder Jit Singh | 07673268 | Jips Pharmaceuticals Private Limited | Director |
| Devinder Kaur Gandhoke | 10849960 | Rudrakyra Production Llp | Designated Partner |
| Shuchi Singh | 10873401 | Rudrakyra Production Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Supreet Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supreet Singh
Supreet Singh currently holds 7 directorships: Psychocare Health Private Limited (Director, since 04 Sep 2018, revenue ₹40.92 Cr (FY 2024)); Jips Pharmaceuticals Private Limited (Director, since 17 Jan 2017, revenue ₹27.63 Cr (FY 2023)); Kyracare Remedies Private Limited (Director, since 18 Mar 2023, revenue ₹1.7 Lakh (FY 2025)); Sehatokart Ventures Private Limited (Director, since 11 Aug 2022, revenue ₹1.3 Lakh (FY 2025)); Rudrakyra Production Llp (Designated Partner, since 16 Dec 2024); and 2 more.
Supreet Singh was first appointed on 20 May 2016 as Director at Fitquest Labs Private Limited. The most recent appointment on record is 16 Dec 2024 at Rudrakyra Production Llp.
The 4 current companies of Supreet Singh that report revenue have a combined latest revenue of ₹68.58 Cr: Psychocare Health Private Limited ₹40.92 Cr (FY 2024); Jips Pharmaceuticals Private Limited ₹27.63 Cr (FY 2023); Kyracare Remedies Private Limited ₹1.7 Lakh (FY 2025); Sehatokart Ventures Private Limited ₹1.3 Lakh (FY 2025).
Supreet Singh held 2 earlier board appointments: Future Generic Private Limited (Director, 25 Mar 2021 to 03 May 2023); Fitquest Labs Private Limited (Director, from 20 May 2016).
The current boards of Supreet Singh's companies include Jagdeep Singh (Psychocare Health Private Limited), Irvandeep Kaur (Jips Pharmaceuticals Private Limited), Parvinder Jit Singh (Jips Pharmaceuticals Private Limited), Devinder Kaur Gandhoke (Rudrakyra Production Llp), Shuchi Singh (Rudrakyra Production Llp).